Covered recipient · General Payments record
JACOB EDWARD RIFFLE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2025
$1,480.19
- Reported across 88 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.52 | 34 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.06 | 14 |
| PFIZER INC. | $93.41 | 5 |
| Verona Pharma, Inc. | $59.56 | 3 |
| Exact Sciences Corporation | $42.68 | 3 |
| Smith+Nephew, Inc. | $30.60 | 2 |
| Novo Nordisk AS | $30.35 | 2 |
| Amgen Inc. | $29.39 | 2 |
| Xeris Pharmaceuticals, Inc. | $16.49 | 1 |
| Acerta Pharma LLC | $15.89 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2025 2021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.58 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861570 | CMS |
| ABBVIE INC. | $14.84 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861575 | CMS |
| ABBVIE INC. | $17.42 | 05/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861582 | CMS |
| ABBVIE INC. | $6.49 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861588 | CMS |
| ABBVIE INC. | $10.23 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861594 | CMS |
| ABBVIE INC. | $12.07 | 06/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861599 | CMS |
| ABBVIE INC. | $11.31 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861607 | CMS |
| ABBVIE INC. | $6.15 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861613 | CMS |
| ABBVIE INC. | $12.27 | 09/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861618 | CMS |
| ABBVIE INC. | $6.65 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861624 | CMS |
| ABBVIE INC. | $3.50 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861630 | CMS |
| ABBVIE INC. | $14.66 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861636 | CMS |
| ABBVIE INC. | $12.18 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861642 | CMS |
| ABBVIE INC. | $15.71 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203861648 | CMS |
| Amgen Inc. | $15.47 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228582827 | CMS |
| Amgen Inc. | $13.92 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227144390 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.89 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206678099 | CMS |
| Exact Sciences Corporation | $15.16 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235419059 | CMS |
| Exact Sciences Corporation | $13.85 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235419063 | CMS |
| Exact Sciences Corporation | $13.67 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235419068 | CMS |
| Novo Nordisk Inc | $14.05 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188799224 | CMS |
| Novo Nordisk Inc | $16.30 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188629174 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.09 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227468786 | CMS |
| PFIZER INC. | $20.32 | 03/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229058478 | CMS |
| PFIZER INC. | $15.77 | 07/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229417454 | CMS |
| PFIZER INC. | $18.68 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229696524 | CMS |
| PFIZER INC. | $21.40 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230331379 | CMS |
| PFIZER INC. | $17.24 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230463032 | CMS |
| Smith+Nephew, Inc. | $15.77 | 03/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242315104 | CMS |
| Smith+Nephew, Inc. | $14.83 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242315106 | CMS |
| Verona Pharma, Inc. | $21.76 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233763276 | CMS |
| Verona Pharma, Inc. | $17.13 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233763204 | CMS |
| Verona Pharma, Inc. | $20.67 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233763198 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.49 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250159960 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.